StockData
Structure Therapeutics Inc. logo

Structure Therapeutics Inc. (GPCR) stock

GPCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$17.36−0.81 (-4.46%)

Close on Nov 18, 2026Market cap $1.24BP/E –Yield –

Structure Therapeutics cash

Cash and short-term investments held at the end of each period.

Structure Therapeutics's cash was $1.34B at Jun 30, 2026. For fiscal 2025 it was $1.45B, up 63.7% from the year before. The highest annual figure on record is $1.45B in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.45B+63.7%
FY2024Dec 31, 2024$883.50M+89.1%
FY2023Dec 31, 2023$467.30M+414.4%
FY2022Dec 31, 2022$90.84M-13.7%
FY2021Dec 31, 2021$105.31M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.34B+70.7%
Q1 FY2026Mar 31, 2026$1.46B+74.3%
Q4 FY2025Dec 31, 2025$1.45B+63.7%
Q3 FY2025Sep 30, 2025$799.00M-12.7%
Q2 FY2025Jun 30, 2025$786.50M-15.2%
Q1 FY2025Mar 31, 2025$836.90M+91.8%
Q4 FY2024Dec 31, 2024$883.50M+89.1%
Q3 FY2024Sep 30, 2024$915.30M+345.6%
Q2 FY2024Jun 30, 2024$927.10M+312.8%
Q1 FY2024Mar 31, 2024$436.40M+81.2%
Q4 FY2023Dec 31, 2023$467.30M+414.4%
Q3 FY2023Sep 30, 2023$205.40M+631.2%
Q2 FY2023Jun 30, 2023$224.60M+304.8%
Q1 FY2023Mar 31, 2023$240.90M+375.9%
Q4 FY2022Dec 31, 2022$90.84M-13.7%
Q3 FY2022Sep 30, 2022$28.09M–
Q2 FY2022Jun 30, 2022$55.49M–
Q1 FY2022Mar 31, 2022$50.62M–
Q4 FY2021Dec 31, 2021$105.31M–

More Structure Therapeutics figures

See a number that looks wrong?